LIVZON PHARMAC. GRP H YC1 (LP6) — Working Capital to Net Assets Ratio
LIVZON PHARMAC. GRP H YC1 (LP6) has a Working Capital to Net Assets ratio of 49.2% as of March 2026. Working capital of €7.67 Billion (current assets of €15.66 Billion minus current liabilities of €7.99 Billion) is measured against net assets of €15.58 Billion. A higher ratio indicates strong short-term liquidity financed by the equity base. See how financially flexible is LIVZON PHARMAC. GRP H YC1 to measure the company's free cash flow as a share of total liabilities.
WC/NA Ratio
Working Capital
Current Assets
Current Liabilities
LIVZON PHARMAC. GRP H YC1 Working Capital to Net Assets (2021–2025)
This chart shows how LIVZON PHARMAC. GRP H YC1's Working Capital to Net Assets ratio has evolved across 5 annual periods from 2021 to 2025. As of March 2026, the ratio stands at 49.2%, reflecting working capital of €7.67 Billion against net assets of €15.58 Billion EUR. See defensive interval ratio of LIVZON PHARMAC. GRP H YC1 to measure how many days the company can operate on defensive assets alone.
Annual Working Capital to Net Assets for LIVZON PHARMAC. GRP H YC1 (2021–2025)
The table below presents the year-by-year Working Capital to Net Assets ratio for LIVZON PHARMAC. GRP H YC1 from 2021 to 2025, covering 5 annual filings. Each row shows current assets, current liabilities, working capital, net assets, the ratio, and the change in percentage points compared to the prior year. For live market cap and the full company profile, see LIVZON PHARMAC. GRP H YC1 (LP6) total market value.
| Year | WC/NA Ratio | Working Capital (EUR) | Net Assets | Current Assets | Current Liabilities | Change (pp) |
|---|---|---|---|---|---|---|
| 2025 | 57.2% | €8.90 Billion | €15.55 Billion | €16.12 Billion | €7.22 Billion | ▼ -1.8 pp |
| 2024 | 59.0% | €8.79 Billion | €14.91 Billion | €16.42 Billion | €7.63 Billion | ▼ -3.2 pp |
| 2023 | 62.2% | €9.18 Billion | €14.77 Billion | €17.27 Billion | €8.09 Billion | ▼ -2.0 pp |
| 2022 | 64.2% | €9.59 Billion | €14.94 Billion | €16.99 Billion | €7.40 Billion | ▲ +10.1 pp |
| 2021 | 54.1% | €7.75 Billion | €14.31 Billion | €14.67 Billion | €6.93 Billion | — |